Europe Mice Model Market

Europe Mice Model Market Size (2023 to 2028)

The mice model market size in Europe is expected to be valued at USD 777 million by 2028 from USD 602.4 million in 2023, growing at a CAGR of 5.22% from 2023 to 2028.

The rising prevalence of chronic diseases across Europe primarily drives the European mice model market growth. The increasing incidence of cancer among the population has resulted in a surge in demand for mice models for research purposes. Mice models are considered one of the most valuable tools in cancer research, serving various purposes such as identifying potential new cancer treatments and determining the underlying causes of cancer. One of the most used models involves injecting mice with cancer cells, maintaining them in a laboratory setting, monitoring the growth of cancer cells in the mice, and testing treatments to eliminate the growing cancer cells. As such, there is a significant demand for mice models in cancer research, and businesses operating in this market can capitalize on this trend by offering high-quality mice models that meet the needs of researchers. By focusing on product quality, research expertise, and customer service, companies can establish a strong foothold in the European mice model market and drive growth in the years ahead.

The growing number of advancements in this field contributes to the growth of the European mice model market. In the wake of the COVID-19 pandemic, there has been a surge in demand for mice models to conduct trials for developing coronavirus vaccines and immune therapies and propelling the European market growth. In addition, rising government support, increasing support from the public and private pharmaceutical sectors and ongoing investments in research and development are other significant factors contributing to the demand for mice models. Companies operating in this market can take advantage of these trends by investing in developing innovative mice models that can cater to the evolving needs of the research community.

The increasing adoption of personalized medicine drives demand for the mice models and fuels the growth rate of the European mice model market. With the success rate of personalized medicine rising, healthcare providers are increasingly recommending personalized treatment options to their patients. This approach has proven to be highly effective in treating diseases faster and with fewer side effects than traditional drugs. As personalized medicine continues to gain popularity among patients and healthcare providers, there is a growing need for high-quality mice models that can accurately replicate human physiology. Companies operating in the mice model market can capitalize on this trend by offering customized mice models that meet the unique needs of researchers and medical professionals.

On the other hand, strict regulations and ethical guidelines governing the use of animals in research majorly hamper the growth of the European mice model market. In addition, the shortage of skilled professionals, as well as the availability of alternative animal testing methods and the occasional failure of mice models, pose challenges to the European mice model market growth. Furthermore, the growing opposition to mice testing by animal welfare organizations presents another challenge to market growth.

This research report on the Europe mice model market has been segmented and sub-segmented into the following categories.

By Type:

• Inbred Mice
• Outbred Mice
• Genetically Engineered Mice
• Hybrid Mice
• Surgically Modified Mice
• Spontaneous Mutant Mice

By Service:

• Breeding
• Cryopreservation
• Model-in Licensing
• Genetic Testing
• Quarantine
• Others

By Technology:

• CRISPR
• Microinjection
• Embryonic Stem Cell Injection
• Nuclear Transfer
• Others

By Indication:

• Oncology Studies
• Immunology & Inflammation Studies
• Endocrine Metabolic Studies
• Cardiovascular Studies
• Central Nervous System (CNS) Studies
• Genetic Studies
• Infectious Disease Studies
• Fibrosis
• Other Disease Studies

By End User:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

By Application:

• Preclinical Drug Development
• Biomarker Analysis
• Basic Cancer Research

By Mode:

• In-House
• Outsourced

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The European mice model market accounted for a considerable share of the worldwide market in 2022 and is anticipated to witness a healthy CAGR during the forecast period owing to the growing healthcare expenditure and an increasing number of workshops on mice models.

Germany had the major share of the European market in 2022 and is estimated to grow at a promising CAGR during the forecast period due to the increasing usage of mice models in the research activities of infectious diseases. These models are crucial in developing vaccines, antibiotics, and antivirals and help implement effective infection control measures. Some of the most pressing infectious diseases facing the country include HIV, Zika virus, hepatitis C virus, malaria, and dengue.

The UK is anticipated to account for a notable share of the European mice model market.

KEY MARKET PLAYERS:

Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Envigo and Janvier Labs are some of the notable companies in the European mice model market.